UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.073

Sortiert nach

A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study

Neuro-oncology (Charlottesville, Va.), 2015-06, Vol.17 (6), p.854-861

2015

Link zum Volltext

Verfügbarkeit prüfen

The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic target

Journal of neurovirology, 1998, Vol.4 (2), p.148-158

1998

Link zum Volltext

Verfügbarkeit prüfen

Subcutaneous Vaccination with Irradiated, Cytokine-Producing Tumor Cells Stimulates CD8$^{+}$ Cell-Mediated Immunity against Tumors Located in the ``Immunologically Privileged" Central Nervous System

Proceedings of the National Academy of Sciences - PNAS, 1996-09, Vol.93 (19), p.10399-10404

1996

Link zum Volltext

Verfügbarkeit prüfen

Maximization of Signal Derived from cDNA Microarrays

BioTechniques, 2001-01, Vol.30 (1), p.202-208

2001

Link zum Volltext

Verfügbarkeit prüfen

Anti-Synthetic Peptide Antibody Reacting at the Fusion Junction of Deletion-Mutant Epidermal Growth Factor Receptors in Human Glioblastoma

Proceedings of the National Academy of Sciences - PNAS, 1990-06, Vol.87 (11), p.4207-4211

1990

Link zum Volltext

Verfügbarkeit prüfen

Interaction of the novel adenosine uptake inhibitor 3-[1-(6,7-diethoxy-2-morpholinoquinazolin-4-yl)piperidin-4-yl]-1,6-dimethyl-2,4(1H,3H)-quinazolinedione hydrochloride (KF24345) with the es and ei subtypes of equilibrative nucleoside transporters

The Journal of pharmacology and experimental therapeutics, 2004-03, Vol.308 (3), p.1083

2004

Link zum Volltext

Verfügbarkeit prüfen

Temozolomide Delivered by Intracerebral Microinfusion is Safe and Efficacious Against Malignant Gliomas in Rats

Clinical cancer research, 2000-10, Vol.6 (10), p.4148-4153

2000

Link zum Volltext

Verfügbarkeit prüfen

Regional Treatment of Epidermal Growth Factor Receptor vIII-expressing Neoplastic Meningitis with a Single-Chain Immunotoxin, MR-1

Clinical cancer research, 1999-09, Vol.5 (9), p.2646-2652

1999

Link zum Volltext

Verfügbarkeit prüfen

Improved targeting of an anti-epidermal growth factor receptor variant III monoclonal antibody in tumor xenografts after labeling using N-succinimidyl 5-iodo-3-pyridinecarboxylate

Cancer research (Chicago, Ill.), 1997-04, Vol.57 (8), p.1510-1515

1997

Link zum Volltext

Verfügbarkeit prüfen

Unarmed, Tumor-Specific Monoclonal Antibody Effectively Treats Brain Tumors

Proceedings of the National Academy of Sciences - PNAS, 2000-06, Vol.97 (13), p.7503-7508

2000

Link zum Volltext

Verfügbarkeit prüfen

Radioimmunotherapy of neoplastic meningitis in rats using an α-particle-emitting immunoconjugate

Cancer research (Chicago, Ill.), 1994-09, Vol.54 (17), p.4719-4725

1994

Link zum Volltext

Verfügbarkeit prüfen

The ECVAM International Validation Study on In Vitro Tests for Skin Corrosivity. 2. Results and Evaluation by the Management Team

Toxicology in vitro, 1998-08, Vol.12 (4), p.483-524

1998

Link zum Volltext

Verfügbarkeit prüfen

Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma

Neuro-oncology (Charlottesville, Va.), 2011-03, Vol.13 (3), p.324-333

2011

Link zum Volltext

Verfügbarkeit prüfen

Nucleoside transporter subtype expression and function in rat skeletal muscle microvascular endothelial cells

British journal of pharmacology, 2004-09, Vol.143 (1), p.202-214

2004

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of compartmental administration of immunotoxin LMB-1 (B3-LysPE38) in a rat model of carcinomatous meningitis

Clinical cancer research, 1995-12, Vol.1 (12), p.1545-1555

1995

Link zum Volltext

Verfügbarkeit prüfen

Intrathecal Administration of Single-Chain Immunotoxin, LMB-7 [B3(Fv)- PE38], Produces Cures of Carcinomatous Meningitis in a Rat Model

Proceedings of the National Academy of Sciences - PNAS, 1995-03, Vol.92 (7), p.2765-2769

1995

Link zum Volltext

Verfügbarkeit prüfen

Temozolomide as a vaccine adjuvant in GBM

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.2020-2020

2007

Link zum Volltext

Verfügbarkeit prüfen

Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies : use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts

Cancer research (Chicago, Ill.), 1995-10, Vol.55 (19), p.4375-4382

1995

Link zum Volltext

Verfügbarkeit prüfen

Intrathecal busulfan treatment of human neoplastic meningitis in athymic nude rats

Journal of neuro-oncology, 1999-01, Vol.44 (3), p.233-241

1999

Link zum Volltext

Verfügbarkeit prüfen

PET Imaging of Osteosarcoma in Dogs Using a Fluorine-18-Labeled Monoclonal Antibody Fab Fragment

The Journal of nuclear medicine (1978), 1994-09, Vol.35 (9), p.1506-1513

1994

Link zum Volltext

Verfügbarkeit prüfen

Generation and characterization of a mouse/human chimeric antibody directed against extracellular matrix protein tenascin

Journal of neuroimmunology, 1994-07, Vol.52 (2), p.127-137

1994

Link zum Volltext

Verfügbarkeit prüfen

Attrition in Randomized Controlled Clinical Trials: Methodological Issues in Psychopharmacology

Biological psychiatry (1969), 2006-06, Vol.59 (11), p.1001-1005

2006

Link zum Volltext

Verfügbarkeit prüfen

Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma

Cancer research (Chicago, Ill.), 2006-03, Vol.66 (6), p.3294-3302

2006

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological analysis and molecular cloning of the canine equilibrative nucleoside transporter 1

European journal of pharmacology, 2004-04, Vol.491 (1), p.9-19

2004

Link zum Volltext

Verfügbarkeit prüfen

Chimeric anti-tenascin antibody 81C6: Increased tumor localization compared with its murine parent

Nuclear medicine and biology, 1996-05, Vol.23 (4), p.449-458

1996

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.073

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(949)
Mit Volltextzugriff
(935)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(684)
Life Sciences & Biomedicine
(550)
Humans
(397)
Female
(243)
Male
(243)
Biological And Medical Sciences
(214)
Animals
(190)
Medical Sciences
(157)
Adult
(121)
Physical Sciences
(110)
Middle Aged
(108)
Aged
(72)
Infant, Newborn
(72)
Rats
(72)
Mice
(71)
Oncology
(68)
Fundamental And Applied Biological Sciences. Psychology
(64)
Pediatrics
(62)
Pharmacology. Drug Treatments
(55)
Risk Factors
(54)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Physical Review. C, Nuclear Physics
(24)
The Journal Of Pediatrics
(21)
Cancer Research
(18)
The Astrophysical Journal
(16)
Pediatrics
(12)
Alzheimer's & Dementia
(11)
Journal Of Clinical Oncology
(10)
Science
(10)
The New England Journal Of Medicine
(10)
Carcinogenesis
(9)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study

The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic target

Subcutaneous Vaccination with Irradiated, Cytokine-Producing Tumor Cells Stimulates CD8$^{+}$ Cell-Mediated Immunity against Tumors Located in the ``Immunologically Privileged" Central Nervous System

Maximization of Signal Derived from cDNA Microarrays

Anti-Synthetic Peptide Antibody Reacting at the Fusion Junction of Deletion-Mutant Epidermal Growth Factor Receptors in Human Glioblastoma

Interaction of the novel adenosine uptake inhibitor 3-[1-(6,7-diethoxy-2-morpholinoquinazolin-4-yl)piperidin-4-yl]-1,6-dimethyl-2,4(1H,3H)-quinazolinedione hydrochloride (KF24345) with the es and ei subtypes of equilibrative nucleoside transporters

Temozolomide Delivered by Intracerebral Microinfusion is Safe and Efficacious Against Malignant Gliomas in Rats

Regional Treatment of Epidermal Growth Factor Receptor vIII-expressing Neoplastic Meningitis with a Single-Chain Immunotoxin, MR-1

Improved targeting of an anti-epidermal growth factor receptor variant III monoclonal antibody in tumor xenografts after labeling using N-succinimidyl 5-iodo-3-pyridinecarboxylate

Unarmed, Tumor-Specific Monoclonal Antibody Effectively Treats Brain Tumors

Radioimmunotherapy of neoplastic meningitis in rats using an α-particle-emitting immunoconjugate

The ECVAM International Validation Study on In Vitro Tests for Skin Corrosivity. 2. Results and Evaluation by the Management Team

Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma

Nucleoside transporter subtype expression and function in rat skeletal muscle microvascular endothelial cells

Efficacy of compartmental administration of immunotoxin LMB-1 (B3-LysPE38) in a rat model of carcinomatous meningitis

Intrathecal Administration of Single-Chain Immunotoxin, LMB-7 [B3(Fv)- PE38], Produces Cures of Carcinomatous Meningitis in a Rat Model

Temozolomide as a vaccine adjuvant in GBM

Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies : use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts

Intrathecal busulfan treatment of human neoplastic meningitis in athymic nude rats

PET Imaging of Osteosarcoma in Dogs Using a Fluorine-18-Labeled Monoclonal Antibody Fab Fragment

Generation and characterization of a mouse/human chimeric antibody directed against extracellular matrix protein tenascin

Attrition in Randomized Controlled Clinical Trials: Methodological Issues in Psychopharmacology

Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma

Pharmacological analysis and molecular cloning of the canine equilibrative nucleoside transporter 1

Chimeric anti-tenascin antibody 81C6: Increased tumor localization compared with its murine parent

Suchergebnisse filtern